hrs-7450
Recombinant proteinexperimental
Clinical trial activity
3 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Oct 31, 2023 (NCT06087094)
Timeline
Indications
Studied for
Mechanism of action
- ThrombinDEGRADER
F2 degrader
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07233070 | Phase 2 | Oct 31, 2025 | Jiangsu ShengDiYa Medicine Co., Ltd. |
| NCT06447415 | Phase 1 | Aug 6, 2024 | Jiangsu ShengDiYa Medicine Co., Ltd. |
| NCT06087094 | Phase 1 | Oct 31, 2023 | Jiangsu ShengDiYa Medicine Co., Ltd. |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Jiangsu ShengDiYa Medicine Co., Ltd. | Government | 3 | 3 | 2 | 2023 |
1 organizations
Page 1 / 1